Q2 26: Investor continues to make the most of a difficult environment
16/07/26 -"Investor confirmed the good start of the year, with good operational development across the board, despite MedTech companies still suffering from cost inflation, pressure on healthcare budgets and ..."
Pages
56
Language
English
Published on
16/07/26
You may also be interested by these reports :
16/07/26
Investor confirmed the good start of the year, with good operational development across the board, despite MedTech companies still suffering from ...
10/07/26
Our EPS for 2026 is benefitting from the announcement of an exceptional dividend by Banijay of €0.93 per share, thus increasing the expected ...
08/07/26
Our EPS for 2026 is benefitting from the positive change in fair value of financial assets of SEK 9bn compared to our last estimate, having a similar ...
08/07/26
Industrivarden has just released good Q2 26 results despite Iran war worries, as it is exposed to names relatively preserved from the Middle East ...